DE69329641T2 - Verfahren zur mehrfachen ligase-kettenreaktion - Google Patents

Verfahren zur mehrfachen ligase-kettenreaktion

Info

Publication number
DE69329641T2
DE69329641T2 DE69329641T DE69329641T DE69329641T2 DE 69329641 T2 DE69329641 T2 DE 69329641T2 DE 69329641 T DE69329641 T DE 69329641T DE 69329641 T DE69329641 T DE 69329641T DE 69329641 T2 DE69329641 T2 DE 69329641T2
Authority
DE
Germany
Prior art keywords
chain reaction
ligase chain
multiple ligase
reaction
ligase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69329641T
Other languages
English (en)
Other versions
DE69329641D1 (de
Inventor
R Bouma
Julian Gordon
Joannel Hoijer
Cynthia Jou
James Rhoads
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69329641D1 publication Critical patent/DE69329641D1/de
Publication of DE69329641T2 publication Critical patent/DE69329641T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4712—Cystic fibrosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6862—Ligase chain reaction [LCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
DE69329641T 1992-03-31 1993-03-31 Verfahren zur mehrfachen ligase-kettenreaktion Expired - Fee Related DE69329641T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86070292A 1992-03-31 1992-03-31
PCT/US1993/003034 WO1993020227A1 (en) 1992-03-31 1993-03-31 Method of multiplex ligase chain reaction

Publications (2)

Publication Number Publication Date
DE69329641D1 DE69329641D1 (de) 2000-12-14
DE69329641T2 true DE69329641T2 (de) 2001-06-21

Family

ID=25333823

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69329641T Expired - Fee Related DE69329641T2 (de) 1992-03-31 1993-03-31 Verfahren zur mehrfachen ligase-kettenreaktion

Country Status (8)

Country Link
EP (2) EP0633944B1 (de)
JP (1) JPH07505293A (de)
AU (1) AU3942993A (de)
CA (1) CA2133220A1 (de)
DE (1) DE69329641T2 (de)
ES (1) ES2153379T3 (de)
TW (1) TW260672B (de)
WO (1) WO1993020227A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10330982A1 (de) * 2003-07-09 2005-02-17 Prisma Diagnostika Gmbh Vorrichtung und Verfahren zur simultanen Bestimmung von Blutgruppenantigenen
DE10330981B4 (de) * 2003-07-09 2010-04-01 Medion Diagnostics Ag Vorrichtung und Verfahren zur simultanen Durchführung von Blutgruppenbestimmung, Serumgegenprobe und Antikörpersuch-Test

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7960494A (en) * 1993-10-21 1995-05-08 Abbott Laboratories Apparatus and method for detecting a target ligand
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
DE69427876T2 (de) * 1994-05-23 2002-04-11 Biotronics Corp Methode zur detektion einer gezielten nukleinsäure
US5667974A (en) * 1995-06-07 1997-09-16 Abbott Laboratories Method for detecting nucleic acid sequences using competitive amplification
SE504798C2 (sv) * 1995-06-16 1997-04-28 Ulf Landegren Immunanalys och testkit med två reagens som kan tvärbindas om de adsorberats till analyten
US5888731A (en) * 1995-08-30 1999-03-30 Visible Genetics Inc. Method for identification of mutations using ligation of multiple oligonucleotide probes
US6764835B2 (en) 1995-12-07 2004-07-20 Diversa Corporation Saturation mutageneis in directed evolution
US6537776B1 (en) 1999-06-14 2003-03-25 Diversa Corporation Synthetic ligation reassembly in directed evolution
AU735440B2 (en) * 1996-02-09 2001-07-05 Cornell Research Foundation Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US6852487B1 (en) 1996-02-09 2005-02-08 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
EP1736554B1 (de) 1996-05-29 2013-10-09 Cornell Research Foundation, Inc. Bestimmung von Unterschieden in der Nukleinsäuresequenz mittels einer Kombination von Ligasebestimmung und Polymerasekettenreaktion
US6312892B1 (en) * 1996-07-19 2001-11-06 Cornell Research Foundation, Inc. High fidelity detection of nucleic acid differences by ligase detection reaction
AU6871798A (en) * 1997-03-28 1998-10-22 Zymogenetics Inc. Human chemokine zsig-35
US6395472B1 (en) 1999-02-05 2002-05-28 Abbott Laboratories Methods of utilizing the TT virus
EP1218536A2 (de) 1999-02-12 2002-07-03 Genset Biallele marker abgeleitet von genomischen regionen, die gene enthalten, die am arachidonsäure stoffwechsel beteiligt sind
AU2001293366A1 (en) 2000-04-14 2001-10-30 Cornell Research Foundation, Inc. Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction
WO2002053768A2 (en) * 2001-01-05 2002-07-11 Diagnosticart Llc Dna rapid immune detection methods and apparatus
CA2456571A1 (en) 2001-08-10 2003-02-20 Genset Sa Human secreted proteins, their encoding polynucleotides, and uses thereof
EP1436621B1 (de) * 2001-09-17 2010-12-22 Phadia AB Mehrfachanalytassay-vorrichtung mit multi-spot-nachweiszone
CA2507125C (en) * 2002-11-25 2014-04-22 Masafumi Matsuo Ena nucleic acid pharmaceuticals capable of modifying splicing of mrna precursors
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
JP4933258B2 (ja) 2003-09-22 2012-05-16 クイデル コーポレーション 試料中の複数分析物の検出装置
WO2005069969A2 (en) 2004-01-21 2005-08-04 University Of Utah Research Foundation Mutant sodium channel nav1.7 and methods related thereto
USRE48960E1 (en) 2004-06-28 2022-03-08 The University Of Western Australia Antisense oligonucleotides for inducing exon skipping and methods of use thereof
EP4272748A3 (de) 2004-06-28 2024-03-27 The University Of Western Australia Antisense-oligonukleotide zur induzierung von exon-skipping und verfahren zur verwendung davon
JP5669397B2 (ja) 2007-03-01 2015-02-12 シムフォゲン・アクティーゼルスカブＳｙｍｐｈｏｇｅｎ Ａ／Ｓ 同族抗体をクローニングするための方法
JP5864257B2 (ja) 2008-10-24 2016-02-17 サレプタ セラピューティクス， インコーポレイテッド Ｄｍｄのための複数のエキソンスキッピング組成物
CN105838714B (zh) 2009-11-12 2020-07-17 西澳大利亚大学 反义分子和治疗疾病的方法
EA035882B1 (ru) 2013-03-14 2020-08-27 Сарепта Терапьютикс, Инк. Антисмысловые олигонуклеотиды, обеспечивающие пропуск экзонов, для лечения мышечной дистрофии
BR112015022998A2 (pt) 2013-03-15 2017-11-14 Sarepta Therapeutics Inc composições melhoradas para o tratamento de distrofia muscular
CN104764877A (zh) * 2014-05-14 2015-07-08 陈岩松 一种免疫层析检测方法及试纸

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435504A (en) * 1982-07-15 1984-03-06 Syva Company Immunochromatographic assay with support having bound "MIP" and second enzyme
US4882269A (en) * 1985-12-13 1989-11-21 Princeton University Amplified hybridization assay
US4855225A (en) * 1986-02-07 1989-08-08 Applied Biosystems, Inc. Method of detecting electrophoretically separated oligonucleotides
DE3887491T2 (de) * 1987-12-21 1994-07-07 Abbott Lab Chromatographische Bindungstesteinrichtungen und Verfahren.
CA1341584C (en) * 1988-04-06 2008-11-18 Bruce Wallace Method of amplifying and detecting nucleic acid sequences
AU629845B2 (en) * 1988-08-30 1992-10-15 Abbott Laboratories Detection and amplification of target nucleic acid sequences
CA1339731C (en) * 1988-10-12 1998-03-17 Charles T. Caskey Multiplex genomic dna amplification for deletion detection
KR950013953B1 (ko) * 1990-01-26 1995-11-18 애보트 래보라토리즈 리가제 연쇄 반응에 적용가능한 표적 핵산의 증폭 방법

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10330982A1 (de) * 2003-07-09 2005-02-17 Prisma Diagnostika Gmbh Vorrichtung und Verfahren zur simultanen Bestimmung von Blutgruppenantigenen
DE10330981B4 (de) * 2003-07-09 2010-04-01 Medion Diagnostics Ag Vorrichtung und Verfahren zur simultanen Durchführung von Blutgruppenbestimmung, Serumgegenprobe und Antikörpersuch-Test

Also Published As

Publication number Publication date
TW260672B (de) 1995-10-21
EP1018649A2 (de) 2000-07-12
JPH07505293A (ja) 1995-06-15
ES2153379T3 (es) 2001-03-01
EP1018649A3 (de) 2000-11-29
EP0633944A4 (de) 1998-02-04
EP0633944A1 (de) 1995-01-18
WO1993020227A1 (en) 1993-10-14
DE69329641D1 (de) 2000-12-14
CA2133220A1 (en) 1993-10-14
EP0633944B1 (de) 2000-11-08
AU3942993A (en) 1993-11-08

Similar Documents

Publication Publication Date Title
DE69329641T2 (de) Verfahren zur mehrfachen ligase-kettenreaktion
DE69119610D1 (de) Verfahren zur mikro-einkapselung von hyperbarem gas
DE69314143D1 (de) Verfahren zur Signal-Rauschverhältnisverbesserung
DE69432015D1 (de) Verfahren
DE69313249D1 (de) Verfahren zur beschränkten Koaleszenz
DE59401597D1 (de) Verfahren zur Überwachung von beweglichen Elementen
DE69432859D1 (de) Verfahren zur reinigung von kollagenase
DE69231871T2 (de) Verfahren zur parallelen Übertragung
DE69316385T2 (de) Verfahren zur reinigung von acetanhydrid
DE3878228T2 (de) Verfahren zur reinigung von stickstoff-fluorid.
DE69325382D1 (de) Verfahren zur oberflächenmodifikation
DE59304051D1 (de) Verfahren zur kurvenfahrterkennung
DE69332556T2 (de) Verfahren zur Mehrfehlerkorrektur
DE69309676T2 (de) Verfahren zur umwandlung von n2o
DE69428364T2 (de) Verfahren zur brandbekämpfung
DE69418318D1 (de) Verfahren zur krafterzeugung
DE69222649D1 (de) Verfahren zur kommunikation
DE69310193T2 (de) Verfahren zur hydroxycarboxylierung der pentensäuren
ATA96197A (de) Verfahren zur reinigung von schadstoffbelasteten gasen
DE69601540T2 (de) Verfahren zur oxychlorierung
DE69225361D1 (de) Katalytisches Verfahren zur Alkylierung
DE68928749D1 (de) Verfahren zur evolventen-interpolation
DE69609963T2 (de) Verfahren zur iodierung
DE59207196D1 (de) Verfahren zur codierung
DE69318223T2 (de) Verfahren zur sprachanalyse

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee